York Pharma plc - Directorate Change

York today announces that it has mutually agreed terms for the departure of Terry Sadler, Founder and President from the Board.

The Company announced yesterday that discussions with Uluru Inc on the proposed terms indicated in the announcement of 7 April 2009 had been terminated and the requirement for the Company to repay to Uluru the million line of credit previously advanced by Uluru to York.  Mr Sadler will resign from the Board of Directors and leave the Company upon the repayment of the line of credit by York.

As announced, York is now actively pursuing alternative funding facilities in order to repay the line of credit before 22 July 2009 and to meet its ongoing working capital requirements.

Commenting on Mr Sadler's departure, Max Dyer-Bartlett, Chairman of the Company said "Terry achieved a tremendous amount in building the York business.  He will leave the Board with our thanks for the effort he has put in for the past six years and for the support he has provided to the new team since their appointment in January this year".